Fox Run Management L.L.C. Invests $370,000 in Zoetis Inc (ZTS)

Fox Run Management L.L.C. purchased a new stake in shares of Zoetis Inc (NYSE:ZTS) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 4,322 shares of the company’s stock, valued at approximately $370,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. grew its position in shares of Zoetis by 1.4% during the 3rd quarter. BlackRock Inc. now owns 37,653,394 shares of the company’s stock valued at $3,447,546,000 after purchasing an additional 522,533 shares in the last quarter. Vanguard Group Inc. grew its position in shares of Zoetis by 0.8% during the 3rd quarter. Vanguard Group Inc. now owns 35,947,496 shares of the company’s stock valued at $3,291,353,000 after purchasing an additional 293,614 shares in the last quarter. Vanguard Group Inc grew its position in shares of Zoetis by 0.8% during the 3rd quarter. Vanguard Group Inc now owns 35,947,496 shares of the company’s stock valued at $3,291,353,000 after purchasing an additional 293,614 shares in the last quarter. Polen Capital Management LLC grew its position in shares of Zoetis by 0.9% during the 3rd quarter. Polen Capital Management LLC now owns 9,374,674 shares of the company’s stock valued at $858,345,000 after purchasing an additional 79,594 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA grew its position in shares of Zoetis by 1.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 7,692,247 shares of the company’s stock valued at $704,302,000 after purchasing an additional 119,154 shares in the last quarter. Hedge funds and other institutional investors own 89.86% of the company’s stock.

Several research analysts recently issued reports on the stock. Zacks Investment Research lowered shares of Zoetis from a “buy” rating to a “hold” rating in a research report on Sunday, January 6th. Argus set a $105.00 target price on shares of Zoetis and gave the stock a “buy” rating in a research report on Tuesday, November 13th. BMO Capital Markets upped their target price on shares of Zoetis to $93.00 and gave the stock a “neutral” rating in a research report on Monday, November 12th. They noted that the move was a valuation call. JPMorgan Chase & Co. upped their target price on shares of Zoetis from $100.00 to $101.00 and gave the stock an “overweight” rating in a research report on Friday, November 2nd. Finally, Morgan Stanley set a $100.00 target price on shares of Zoetis and gave the stock a “hold” rating in a research report on Friday, November 2nd. Seven equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $94.00.

Zoetis stock opened at $84.25 on Friday. The company has a quick ratio of 2.63, a current ratio of 4.06 and a debt-to-equity ratio of 3.04. The firm has a market capitalization of $40.75 billion, a price-to-earnings ratio of 35.10, a price-to-earnings-growth ratio of 1.50 and a beta of 1.01. Zoetis Inc has a twelve month low of $70.20 and a twelve month high of $96.57.

Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Thursday, November 1st. The company reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.77 by $0.06. The business had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.46 billion. Zoetis had a net margin of 20.35% and a return on equity of 75.51%. The firm’s revenue for the quarter was up 9.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.65 earnings per share. On average, equities analysts anticipate that Zoetis Inc will post 3.11 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 1st. Shareholders of record on Friday, January 18th will be paid a $0.164 dividend. The ex-dividend date of this dividend is Thursday, January 17th. This is an increase from Zoetis’s previous quarterly dividend of $0.13. This represents a $0.66 annualized dividend and a yield of 0.78%. Zoetis’s payout ratio is currently 20.83%.

Zoetis declared that its Board of Directors has approved a stock repurchase plan on Wednesday, December 12th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to purchase up to 4.7% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s management believes its stock is undervalued.

In other Zoetis news, CEO Juan Ramon Alaix sold 150,306 shares of the business’s stock in a transaction on Thursday, November 8th. The shares were sold at an average price of $94.96, for a total value of $14,273,057.76. Following the completion of the sale, the chief executive officer now directly owns 246,319 shares of the company’s stock, valued at $23,390,452.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Willie M. Reed sold 3,205 shares of the business’s stock in a transaction on Friday, November 30th. The stock was sold at an average price of $93.74, for a total transaction of $300,436.70. Following the completion of the sale, the director now directly owns 566 shares of the company’s stock, valued at $53,056.84. The disclosure for this sale can be found here. Insiders sold 177,636 shares of company stock valued at $16,760,351 over the last three months. 0.35% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION WARNING: “Fox Run Management L.L.C. Invests $370,000 in Zoetis Inc (ZTS)” was originally posted by WKRB News and is the property of of WKRB News. If you are reading this report on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.wkrb13.com/2019/01/18/fox-run-management-l-l-c-invests-370000-in-zoetis-inc-zts.html.

About Zoetis

Zoetis Inc discovers, develops, manufactures, and markets veterinary vaccines and medicines in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

Featured Article: What is a Roth IRA?

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply